Out-of-pocket payment and financial risk protection for breast cancer treatment: a prospective study from India
Tabassum Wadasadawala(Homi Bhabha National Institute), Vani Parmar(Tata Memorial Hospital), Rajiv Sarin(Advanced Centre for Treatment, Research and Education in Cancer), Tejaswi S. Kanala(Homi Bhabha National Institute), Soumendu Sen(International Institute for Population Sciences), Namita Puchali(Homi Bhabha National Institute), Suraj Maiti(International Institute for Population Sciences), Sudeep Gupta(Tata Memorial Hospital), Sanjay K. Mohanty(International Institute for Population Sciences)
Cited by 28
Related Papers
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
Disease-specific out-of-pocket and catastrophic health expenditure on hospitalization in India: Do Indian households face distress health financing?
|PLoS ONE|2018|303
Monogenic and polygenic determinants of sarcoma risk: an international genetic study
|The Lancet Oncology|2016|213
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
|Contemporary Clinical Trials|2016|162
Breast cancer: An overview of published Indian data
|South Asian Journal of Cancer|2016|82